Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.34
TRNX's Cash to Debt is ranked higher than
53% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. TRNX: 0.34 )
TRNX' s 10-Year Cash to Debt Range
Min: 0.18   Max: No Debt
Current: 0.34

Equity to Asset 0.74
TRNX's Equity to Asset is ranked higher than
79% of the 446 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. TRNX: 0.74 )
TRNX' s 10-Year Equity to Asset Range
Min: 0.42   Max: 0.79
Current: 0.74

0.42
0.79
F-Score: 5
Z-Score: 4.45
M-Score: -2.69
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -7.37
TRNX's Operating margin (%) is ranked higher than
61% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. TRNX: -7.37 )
TRNX' s 10-Year Operating margin (%) Range
Min: -16.1   Max: -2.74
Current: -7.37

-16.1
-2.74
Net-margin (%) -9.44
TRNX's Net-margin (%) is ranked higher than
60% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. TRNX: -9.44 )
TRNX' s 10-Year Net-margin (%) Range
Min: -27.11   Max: -7.84
Current: -9.44

-27.11
-7.84
ROE (%) -6.16
TRNX's ROE (%) is ranked higher than
62% of the 443 Companies
in the Global Medical Devices industry.

( Industry Median: 5.20 vs. TRNX: -6.16 )
TRNX' s 10-Year ROE (%) Range
Min: -23.74   Max: -5.19
Current: -6.16

-23.74
-5.19
ROA (%) -4.58
TRNX's ROA (%) is ranked higher than
63% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. TRNX: -4.58 )
TRNX' s 10-Year ROA (%) Range
Min: -10.97   Max: -3.73
Current: -4.58

-10.97
-3.73
ROC (Joel Greenblatt) (%) -17.58
TRNX's ROC (Joel Greenblatt) (%) is ranked higher than
63% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 9.15 vs. TRNX: -17.58 )
TRNX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -31.25   Max: -4.56
Current: -17.58

-31.25
-4.56
Revenue Growth (3Y)(%) -6.10
TRNX's Revenue Growth (3Y)(%) is ranked higher than
60% of the 340 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. TRNX: -6.10 )
TRNX' s 10-Year Revenue Growth (3Y)(%) Range
Min: -6.1   Max: -2.7
Current: -6.1

-6.1
-2.7
EPS Growth (3Y)(%) -17.80
TRNX's EPS Growth (3Y)(%) is ranked higher than
67% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. TRNX: -17.80 )
TRNX' s 10-Year EPS Growth (3Y)(%) Range
Min: -38.1   Max: -17.8
Current: -17.8

-38.1
-17.8
» TRNX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

TRNX Guru Trades in Q3 2013

Jim Simons 61,400 sh (New)
Paul Tudor Jones Sold Out
Steven Cohen 530,855 sh (-36.7%)
» More
Q4 2013

TRNX Guru Trades in Q4 2013

Jim Simons Sold Out
Steven Cohen Sold Out
» More
Q1 2014

TRNX Guru Trades in Q1 2014

Steven Cohen 176,057 sh (New)
» More
Q3 2014

TRNX Guru Trades in Q3 2014

Steven Cohen 269,700 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with TRNX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 2.64
TRNX's P/B is ranked higher than
78% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.95 vs. TRNX: 2.64 )
TRNX' s 10-Year P/B Range
Min: 1.47   Max: 2.79
Current: 2.64

1.47
2.79
P/S 3.84
TRNX's P/S is ranked higher than
68% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. TRNX: 3.84 )
TRNX' s 10-Year P/S Range
Min: 2.22   Max: 4.06
Current: 3.84

2.22
4.06
Current Ratio 2.59
TRNX's Current Ratio is ranked higher than
71% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.79 vs. TRNX: 2.59 )
TRNX' s 10-Year Current Ratio Range
Min: 2.19   Max: 3.29
Current: 2.59

2.19
3.29
Quick Ratio 1.39
TRNX's Quick Ratio is ranked higher than
62% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. TRNX: 1.39 )
TRNX' s 10-Year Quick Ratio Range
Min: 1.18   Max: 1.99
Current: 1.39

1.18
1.99

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 9.13
TRNX's Price/Tangible Book is ranked higher than
64% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 6.92 vs. TRNX: 9.13 )
TRNX' s 10-Year Price/Tangible Book Range
Min: 4.08   Max: 11.71
Current: 9.13

4.08
11.71
Price/Median PS Value 1.35
TRNX's Price/Median PS Value is ranked higher than
66% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. TRNX: 1.35 )
TRNX' s 10-Year Price/Median PS Value Range
Min: 0.85   Max: 1.34
Current: 1.35

0.85
1.34
Earnings Yield (Greenblatt) -1.80
TRNX's Earnings Yield (Greenblatt) is ranked higher than
64% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. TRNX: -1.80 )
TRNX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0   Max: 0
Current: -1.8

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:T98.Germany,
Tornier NV is a medical device company founded in the year 1940. The Company, along with its subsidiaries, provides solutions to surgeons that treat musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot, which refers to as "extremity joints." It sells to these surgeons a joint replacement, trauma, sports medicine and biologic products to treat extremity joints. In foreign markets, the Company also offers joint replacement products for the hip and knee. Its customers are surgeon specialists focused on extremity injuries and disorders, along with general surgeons and podiatrists that perform extremities-related surgical procedures. The Company competes with orthopaedic manufacturers, such as DePuy Orthopaedics, Inc., a Johnson & Johnson subsidiary, Biomet, Inc., Zimmer Corporation and Stryker Corporation, and established mid-sized orthopaedic manufacturers, such as Arthrex, Inc., Wright Medical Group, Inc., Exactech, Inc., Integra LifeSciences Corporation and ArthroCare Corporation. The Company is subject to regulation by the U.S. Food and Drug Administration, other federal governmental agencies and state agencies in the United States and similar foreign governmental authorities in countries located outside the United States.
» More Articles for TRNX

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
Tornier to Present at Piper Jaffray 26th Annual Healthcare Conference Nov 19 2014
TORNIER N.V. Financials Nov 14 2014
Tornier misses 3Q profit forecasts Nov 06 2014
Tornier misses 3Q profit forecasts Nov 06 2014
TORNIER N.V. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 06 2014
Tornier Reports Third Quarter 2014 Results Nov 06 2014
Q3 2014 Tornier NV Earnings Release - After Market Close Nov 06 2014
Tornier N.V. (TRNX) Jumps: Stock Moves 7.9% Higher Oct 29 2014
WRIGHT MEDICAL GROUP, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of... Oct 28 2014
Tornier (TRNX) Stock Soars Today After Acquiring Wright Medical Group (WMGI) Oct 28 2014
Wright Medical, Tornier to Combine in $3.3 Billion Deal Oct 28 2014
[$$] Wright Medical, Tornier to Combine Oct 27 2014
Wright Medical Group, Inc. and Tornier N.V. Agree to Merge Creating Premier High-Growth... Oct 27 2014
Wright Medical Will Merge With Tornier in All-Stock Deal Oct 27 2014
Tornier Announces Third Quarter 2014 Revenue and Increases 2014 Revenue Guidance Oct 27 2014
Wright Medical Group, Inc. and Tornier N.V. Agree to Merge Creating Premier High-Growth... Oct 27 2014
TORNIER N.V. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations... Oct 27 2014
Tornier Announces Third Quarter 2014 Revenue and Increases 2014 Revenue Guidance Oct 27 2014
Wright Medical Group, Inc. and Tornier N.V. Agree to Merge Creating Premier High-Growth... Oct 27 2014
Tornier Announces Third Quarter 2014 Conference Call Oct 22 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK